finance.foundation / Companies / ROG vs MRK
Comparison · seed-0.6 · 2026-08-29
Roche (ROG) vs Merck & Co. (MRK)
Roche (ROG) and Merck & Co. (MRK) side by side: both in Healthcare, listed on SIX Swiss Exchange and New York Stock Exchange. Roche is the larger of the two by approximate market capitalization (about 1.0×).
| Field | Roche | Merck & Co. |
|---|---|---|
| Legal name | Roche Holding AG | Merck & Co., Inc. |
| Ticker | ROG | MRK |
| Exchange | SIX Swiss Exchange XSWX | New York Stock Exchange XNYS |
| Jurisdiction | Switzerland | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals and diagnostics | Pharmaceuticals |
| Market cap ≈ | $260bn | $250bn |
| Founded | 1896 | 1891 |
| Reporting currency | CHF | USD |
| LEI | 549300U41AUUVOAAOB37 | 4YV9Y5M8S0BRK1RP0397 |
| ISIN | CH0012032048 | US58933Y1055 |
| FIGI | BBG001SD12S2 | BBG001S5TC52 |
| Index membership | — | S&P 500 |
| Held by (covered funds) | — | — |
Roche
Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.
Merck & Co.
US pharmaceutical major (known as MSD outside North America) whose cancer immunotherapy Keytruda is among the world's best-selling drugs; also strong in vaccines and animal health.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/roche · /api/v1/companies/merck